PB Fintech Shares Crash 42% in Four Days: Why Jefferies and Bernstein Still See Strong Upside
PB Fintech shares have faced one of their sharpest corrections in recent years, losing about 42% across four trading sessions and wiping out nearly ₹37,000 crore from the company’s market value. Yet, despite the dramatic sell-off, global brokerages Jefferies and Bernstein continue to see substantial value in the Policybazaar parent.
The sharp decline has been triggered largely by proposed changes from the Insurance Regulatory and Development Authority of India (IRDAI) that could significantly alter the economics of insurance distribution.
PB Fintech Shares Face Heavy Selling
PB Fintech shares fell another 6% on September 29, touching around ₹1,082 on the BSE. This extended the stock’s four-session decline to approximately 42%.
The scale of the correction reflects investor concerns that changes to insurance commissions and distribution costs could affect the company's future earnings and business economics.
The sell-off followed IRDAI's consultation proposals covering commission structures, expenses of management and online insurance-selling practices.
Why IRDAI's Proposals Matter
The regulatory proposals could change how insurers compensate distributors across products and channels.
Among the areas attracting attention are commission limits for different types of insurance, changes to distribution economics and restrictions on certain online practices described as "dark patterns."
IRDAI has also proposed a simplified framework covering Insurance Distribution Entities, Insurance Distribution Persons and Market Infrastructure Institutions.
The broader objective outlined by the regulator is to reduce insurance costs, improve access and create a more sustainable distribution framework.
For PB Fintech, however, the key issue is how lower commissions could affect the economics of acquiring and servicing insurance customers.
Jefferies Cuts Target Price but Retains Buy Rating
Jefferies has reduced its target price for PB Fintech from ₹2,050 to ₹1,540 while maintaining its Buy rating.
The brokerage estimates that if proposed commission reductions are implemented, the net present value of PB Fintech's non-life insurance business could fall substantially from existing levels.
Jefferies has also estimated that a 10% reduction in new-business commission rates could potentially translate into a 10-12% decline in earnings.
At the same time, the brokerage believes life insurance economics could remain comparatively stable, partly because higher renewal commissions in term insurance could offset some of the pressure.
Jefferies has also lowered the valuation multiple it applies to Policybazaar, reflecting the increased uncertainty around future insurance take rates.
Bernstein Sees a Very Different Long-Term Picture
While Jefferies has become more conservative on valuation, Bernstein remains significantly more optimistic.
Bernstein has retained its Outperform rating and a ₹2,310 target price. Based on the stock price referenced in the latest report, that target represented potential upside of roughly 100%.
However, Bernstein's view does not ignore the regulatory risk.
The brokerage expects PB Fintech to respond by reducing direct costs as growth spending moderates. It also expects a phased reduction in indirect costs during FY28 and FY29.
In other words, Bernstein's argument is partly based on the possibility that PB Fintech can protect profitability through cost discipline while adapting to the new regulatory environment.
The Important Difference Between the Two Brokerage Views
The contrast between Jefferies and Bernstein is significant.
Jefferies is placing greater emphasis on the immediate uncertainty surrounding commissions and valuation. Bernstein is giving more weight to potential cost optimisation and the company's ability to adjust its business model.
This explains why two brokerages can reach very different target prices even after looking at the same regulatory proposal.
It also highlights an important point for investors: brokerage targets are based on assumptions and scenarios, not guaranteed future share prices.
PB Fintech May Need to Change Its Growth Strategy
The regulatory proposals could force PB Fintech to reconsider how aggressively it spends on customer acquisition.
According to the latest brokerage commentary, the company could slow hiring and reduce marketing expenses in response to the changing economics.
That could support profitability in the short term, but there is also a trade-off.
Lower spending could reduce losses and improve cash efficiency, but excessive cost-cutting could potentially affect customer acquisition and future growth.
The company's ability to balance these two factors may become an important part of the investment story.
Other Businesses Could Become More Important
PB Fintech is not dependent on a single business opportunity.
The company has been evaluating additional areas including insurance manufacturing, reinsurance broking, new insurance products and the possibility of operating as a managing general agent, or MGA.
It is also working on reducing losses in businesses such as Paisabazaar and its UAE operations.
If the traditional insurance distribution model becomes less profitable, these additional businesses could become increasingly important to the company's longer-term growth strategy.
What Investors Should Watch Now
The most important development may not be the stock's immediate price movement but the final form of the IRDAI regulations.
The current proposals are part of a consultation process, meaning the framework could change following industry and public feedback.
Investors should therefore watch several factors closely:
- Final commission limits announced by IRDAI
- The impact on PB Fintech's insurance take rates
- Changes in customer acquisition costs
- Growth in Policybazaar's insurance business
- Cost reductions and operating efficiency
- Performance of Paisabazaar and other businesses
- Progress in new insurance-related opportunities
- Whether the company's valuation adjusts to the new earnings environment
The consultation process is therefore an important near-term catalyst for the stock.
The Bigger Picture
The PB Fintech sell-off shows how strongly regulatory changes can affect companies whose business models depend on distribution economics.
The market has already priced in a significant amount of uncertainty, with the stock losing around 42% over four sessions.
At the same time, the sharply different brokerage targets demonstrate that there is considerable disagreement over what PB Fintech's earnings and business model could look like after the regulatory transition.
Jefferies has reduced its target to ₹1,540, while Bernstein continues to use a ₹2,310 target. These figures should be viewed as brokerage estimates based on their respective assumptions rather than as predictions of where the stock will trade.
For investors tracking PB Fintech, the central question now is how successfully the company can adapt its costs, product mix and growth strategy if the proposed insurance distribution changes become final.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the final regulatory framework, company disclosures and independent research before making investment decisions.
